What is the purpose of this trial?Impaired endothelial function is observed in disease states related to obesity, such as atherosclerosis, coronary artery disease, and diabetes. Reactive oxygen species (ROS) production and resultant oxidative stress contribute to the development of these obesity-related diseases. The enzyme NADPH-oxidase is a major source of oxidative stress within the vasculature, and has been linked with the Metabolic Syndrome. In the investigator's previously funded studies, the investigators demonstrated for the first time that: 1) in vivo ROS were elevated in skeletal muscle of obese as compared to lean or overweight human subjects, 2) perfusion of the NADPH-oxidase inhibitor apocynin locally into muscle normalized ROS levels and reversed local microvascular endothelial dysfunction in the obese individuals, and 3) aerobic exercise training was effective at attenuating in vivo hydrogen peroxide production and reversing microvascular endothelial dysfunction in the obese individuals. The investigators will investigate in this R15 renewal application the mechanism of exercise training-induced alterations in ROS production and action on endothelial dysfunction in obesity using our newly developed microdialysis methodology of monitoring ROS production, in combination with analysis of muscle biopsy samples obtained before and after our previously tested 8-week intervention of aerobic interval exercise training. The objectives of this study are to determine the impact of in vivo NADPH oxidase activity on endothelial function in obese individuals, and to determine the mechanism of training-induced improvements in endothelial function. The investigator's unique microdialysis methodology will allow monitoring of microvascular/endothelial function and ROS generation, as well as the administration of pharmacological agents directly into muscle. The central hypothesis is that it is upregulation of both mitochondrial ROS and NADPH oxidase-derived ROS that results in endothelial dysfunction in obesity, and that exercise training down-regulates mitochondrial-derived ROS, and NADPH oxidase 4, thereby improving endothelial function. The aims of this proposal are to: 1) determine the contributions of mitochondrial ROS and specific NADPH oxidase isoforms to the NADPH oxidase dependent endothelial dysfunction in skeletal muscle of obese individuals; 2) determine the mechanism of ROS reduction and improved endothelial function resulting from an 8-week aerobic interval training program.
Will I have to stop taking my current medications?The trial requires that participants not take medications that affect circulation, nonsteroidal anti-inflammatory drugs, or serotonin reuptake inhibitors. If you are on these medications, you may need to stop taking them to participate.
What data supports the effectiveness of the treatment Exercise, Physical Activity, Workout, Fitness Training for obesity?Research shows that exercise helps people with obesity by improving physical performance, quality of life, and reducing body weight and fat mass. It also enhances cardiovascular health and helps maintain muscle strength during weight loss.
12345 Is exercise safe for people with obesity?Exercise is generally safe for people with obesity and offers many health benefits, such as improved cardiovascular health and better weight management. However, it's important to tailor the type and intensity of exercise to individual needs and consult with healthcare professionals to ensure safety.
12678 How does exercise as a treatment for obesity differ from other treatments?Exercise for obesity is unique because it not only helps with weight and fat loss but also improves overall fitness and health, even if weight loss is modest. Unlike other treatments, exercise can enhance cardiovascular health, increase muscle strength, and improve quality of life, making it an essential part of managing obesity.
126910